Peripheral Artery Disease (PAD): Symptoms, Diagnosis, and Treatment

Citable definition: Peripheral artery disease (PAD) is a chronic atherosclerotic (plaque-related narrowing of the arteries) condition in which reduced blood flow to the lower limbs causes symptoms ranging from leg pain on exertion to non-healing wounds and limb-threatening ischemia (critically insufficient blood supply). It affects an estimated 200 million people worldwide and is a powerful marker of systemic cardiovascular risk (Hirsch AT et al., JAMA, 2001; Belch JJF et al., Arch Intern Med, 2003).

What Is Peripheral Artery Disease?

Peripheral artery disease is, at its core, a plumbing problem. Over years, fatty deposits called plaques accumulate inside the walls of the arteries that supply the legs — and sometimes the arms — gradually narrowing the channel through which blood flows. This process, known as atherosclerosis (hardening and narrowing of the arteries), is the same mechanism responsible for most heart attacks and strokes.

Because the legs are the furthest point from the heart, they are often the first to feel the consequences of reduced arterial flow. When demand rises — during walking, climbing stairs, or exercise — the narrowed arteries simply cannot keep up, and muscles cry out with pain or cramping. In advanced stages, blood flow is so restricted that pain occurs even at rest, and wounds on the feet or toes may refuse to heal, raising the risk of amputation.

PAD is far more common than many people realize. A landmark survey found it affects roughly 8–12% of adults over 50 in Western countries, yet awareness remains alarmingly low (Hirsch AT et al., JAMA, 2001, PMID: 11565520). For a broader look at arterial conditions, visit our arteries section.

Also available in French

Symptoms: What PAD Feels Like

PAD progresses through recognizable stages. The Fontaine classification (a widely used European staging system) and the Rutherford categories (preferred in North America) both describe a spectrum from silent disease to critical limb-threatening ischemia (CLTI).

Stage 1 — Asymptomatic

Many patients have significant arterial narrowing without any symptoms. PAD at this stage is often discovered incidentally during a cardiovascular check-up.

Stage 2 — Intermittent Claudication (the most searched symptom)

Intermittent claudication — cramping, aching, or fatigue in the calf, thigh, or buttock that begins predictably after a set walking distance and resolves within minutes of rest — is the signature symptom of PAD. It mirrors “angina of the legs.” Patients frequently describe it as a “charley horse” that forces them to stop walking.

Stage 3 — Rest Pain

When narrowing becomes severe, pain occurs even while lying down, typically in the foot and toes. Patients often hang their leg over the bed edge for relief, using gravity to eke out a little more blood flow.

Stage 4 — Tissue Loss

Non-healing ulcers (open sores), gangrene (tissue death), or both signal critical limb-threatening ischemia. This is a vascular emergency requiring urgent specialist care.

Other warning signs to know:

• Leg or foot that is persistently cold, pale, or bluish compared to the other side
• Weak or absent pulse in the foot
• Shiny, hairless skin on the lower leg
• Slow-growing toenails

⚠️ Sudden severe leg pain with pallor and coldness may indicate acute limb ischemia — a vascular emergency. Call emergency services immediately.

Diagnosis: What to Expect

The Ankle-Brachial Index (ABI)

The first-line diagnostic test is the ankle-brachial index (ABI) — a simple, non-invasive ratio of blood pressure measured at the ankle versus the upper arm. An ABI below 0.90 confirms PAD; below 0.40 signals critical ischemia. It takes about 15 minutes and requires no special preparation.

Duplex Ultrasound

Color duplex ultrasound (a scan combining standard ultrasound with Doppler blood-flow measurement) maps the location and severity of narrowings without radiation or contrast dye. It is the workhorse of vascular laboratories across Europe and North America.

Pressure Indices Beyond ABI

Research is exploring more sophisticated hemodynamic (blood-flow) measurements borrowed from cardiology. A 2026 review published in Vascular and Endovascular Surgery examined the potential of fractional flow reserve (FFR) — a pressure-based index already standard in coronary artery disease — to guide PAD treatment decisions more precisely (Karia K et al., Vasc Endovasc Surg, 2026, PMID: 41259709). While promising, these techniques are not yet standard of care.

CT Angiography and MR Angiography

When intervention is planned, cross-sectional imaging — CT angiography (a detailed X-ray scan of the arteries using contrast dye) or MR angiography (the same concept using magnetic resonance) — provides a road map of the entire arterial tree from the aorta to the foot.

Digital Subtraction Angiography (DSA)

The gold standard for arterial imaging, DSA involves threading a thin catheter into the artery and injecting contrast dye under live X-ray. It is usually reserved for patients about to undergo an endovascular (inside-the-vessel) procedure.

Treatment: From Lifestyle to Surgery

Treatment follows a stepwise approach endorsed by both the European Society for Vascular Surgery (ESVS) and the American Heart Association / American College of Cardiology (AHA/ACC). The goal is twofold: relieve symptoms and reduce the heightened risk of heart attack and stroke that comes with PAD.

1. Conservative Management (All Patients)

A noteworthy 2026 clinical trial published in JAMA — the PERMET trial — tested whether metformin (a diabetes medication with potential effects on skeletal muscle metabolism) could improve walking performance in PAD patients without diabetes. The results did not demonstrate a significant benefit over placebo for walking distance, underscoring that not every promising agent translates into clinical gain (McDermott MM et al., JAMA, 2026 Feb 3, PMID: 41205146).

2. Endovascular (Minimally Invasive) Procedures

When symptoms remain disabling despite optimal medical therapy, or when limb viability is threatened, interventional options are considered.

Balloon Angioplasty (PTA — Percutaneous Transluminal Angioplasty) A tiny balloon is inflated inside the narrowed artery to widen it. Beyond restoring flow, a 2026 study in the Annals of Vascular Surgery found that PTA also significantly reduces circulating inflammatory biomarkers (substances in the blood that signal arterial wall inflammation), suggesting the procedure has biological benefits beyond simple mechanical widening (Beyaz GK et al., Ann Vasc Surg, 2026 May, PMID: 41534713).

Stenting When a segment of artery recoils after angioplasty or re-narrows (restenosis), a metal scaffold called a stent is deployed to keep it open. A 2026 randomized trial compared interwoven nitinol stents (a newer, more flexible design) with conventional self-expandable nitinol stents in patients with complex femoropopliteal (thigh-level artery) disease. The interwoven design showed favorable patency (vessel-remaining-open) rates in this challenging anatomy (Meshref MM et al., Ann Vasc Surg, 2026 Apr, PMID: 41485641).

Bioresorbable Vascular Scaffolds (BVS) An emerging technology, BVS dissolves over time once the artery has healed, potentially avoiding the long-term complications of permanent metal. A 2026 systematic review and meta-analysis evaluated BVS specifically in below-the-knee arterial disease — historically the most technically demanding territory — and reported acceptable technical success and limb-salvage rates, though larger trials are needed (Cui HJ et al., Ann Vasc Surg, 2026 Apr, PMID: 41500331).

Post-Procedure Anticoagulation After revascularization (restoring blood flow), preventing re-clotting is critical. A 2026 study in the Annals of Vascular Surgery examined how common thromboprophylactic (clot-preventing) drug regimens affect thrombin generation (the body’s clotting cascade activity) following PAD revascularization, providing data to help clinicians choose the most effective post-operative anticoagulation strategy (Bucha S et al., Ann Vasc Surg, 2026 Apr, PMID: 41506341).

3. Open Surgical Bypass

When endovascular options are not feasible — typically due to very long or heavily calcified occlusions — surgeons can bypass the blocked segment using either a vein harvested from the patient’s own leg or a synthetic graft. Bypass surgery carries higher short-term risk but can provide durable results in carefully selected patients.

For a complete overview of vascular treatment options, visit our treatments section.

Prevention: Protecting Your Arteries Every Day

The same risk factors that cause coronary artery disease fuel PAD. Addressing them early is the most powerful intervention available:

1. Never smoke — or quit today. Smoking is the single strongest modifiable risk factor for PAD.
2. Move more. Even 30 minutes of brisk walking five days a week strengthens collateral circulation.
3. Control blood sugar. Diabetes doubles PAD risk and dramatically worsens outcomes.
4. Know your blood pressure. Target below 130/80 mmHg per current AHA/ACC guidelines.
5. Manage cholesterol. LDL (low-density lipoprotein, the “bad” cholesterol) should be below 70 mg/dL in high-risk individuals.
6. Inspect your feet daily if you have diabetes — small wounds can escalate rapidly when circulation is poor.
7. Ask about ABI screening if you are over 65, or over 50 with a history of smoking or diabetes.

Visit our prevention section for more evidence-based strategies.

When to See a Doctor

Seek a routine vascular appointment if you notice:

• Leg cramping or fatigue that consistently occurs after walking and resolves with rest
• One foot or leg that is persistently colder or paler than the other
• A wound on your foot or lower leg that is slow to heal
• You are over 50 with diabetes, a history of smoking, or known cardiovascular disease

Go to an emergency department immediately if you experience:

• Sudden, severe leg pain combined with coldness, pallor, or numbness — this may be acute limb ischemia
• A non-healing wound that is rapidly enlarging, darkening, or developing a foul odor

Early diagnosis saves limbs and lives. Do not wait for symptoms to become severe before consulting your physician or vascular specialist.

Sources

1. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317-1324. PMID: 11565520. https://doi.org/10.1001/jama.286.11.1317

2. Belch JJF, Topol EJ, Agnelli G, et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003;163(8):884-892. https://doi.org/10.1001/archinte.163.8.884

3. McDermott MM, Domanchuk KJ, Tian L, et al. Metformin to Improve Walking Performance in Lower Extremity Peripheral Artery Disease: The PERMET Randomized Clinical Trial. JAMA. 2026 Feb 3;335(5):407-415. PMID: 41205146. https://doi.org/10.1001/jama.2025.21358

4. Beyaz GK, Beyaz MO, Tas SK. Effect of Percutaneous Transluminal Balloon Angioplasty on Inflammatory Biomarkers in Patients with Peripheral Arterial Disease. Ann Vasc Surg. 2026 May;126:72-83. PMID: 41534713. https://doi.org/10.1016/j.avsg.2025.12.039

5. Bucha S, Cieri IF, Rodriguez AA, Boya MN, Patel S, Dua A. The Impact of Common Thromboprophylactic Regimens on Thrombin Generation in Patients with Peripheral Artery Disease Postrevascularization. Ann Vasc Surg. 2026 Apr;125:112-121. PMID: 41506341. https://doi.org/10.1016/j.avsg.2025.12.026

6. Cui HJ, Li ML, Wu YF. Efficacy of Bioresorbable Vascular Scaffolds in Below-the-Knee Arterial Disease: A Single-Arm Systematic Review and Meta-Analysis. Ann Vasc Surg. 2026 Apr;125:206-217. PMID: 41500331. https://doi.org/10.1016/j.avsg.2025.12.027

7. Meshref MM, Abdel-Malek WF, Hanafy AA, Zaki MM. A Randomized Trial Comparing Interwoven and Self-Expandable Nitinol Stents in Trans-Atlantic Inter-Society Consensus II C and D Femoropopliteal Arterial Disease. Ann Vasc Surg. 2026 Apr;125:248-258. PMID: 41485641. https://doi.org/10.1016/j.avsg.2025.12.031

8. Karia K, Al-Rekabi A, Suseeharan M, Bahl R, Hamady M. The Use of Pressure Indices, Such as Fractional Flow Reserve, in Peripheral Arterial Disease — A Review of Current Literature and Potential Prospects. Vasc Endovasc Surg. 2026 Apr;60(3):271-282. PMID: 41259709. https://doi.org/10.1177/15385744251394835

Medical Disclaimer: This article is produced by the Petit Veinard Editorial Board for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician or vascular specialist before making any healthcare decisions. In the event of a medical emergency, contact your local emergency services immediately. Petit Veinard is an independent media outlet and has no financial relationship with any pharmaceutical or medical device company mentioned in this article.